Skip to content

SYNERGY Stent in Korean Patients with Acute Coronary Syndrome

SYNERGY Stent in Korean Patients with Acute Coronary Syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0006022
Enrollment
960
Registered
2021-03-24
Start date
2016-10-24
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Chonnam National University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: -Patients=18 years of age Patients with ACS -Patients with lesions requiring interventions amendable for implantation of SYNERGY during the index procedure.

Exclusion criteria

Exclusion criteria: -Female of childbearing potential, who possibly plans to become pregnant any time after enrollment into this study. -Patients with hypersensitivity or allergies to one the drug or components indicated in the Instructions for Use of the stent. -Patients with a life expectancy shorter than 3 years

Design outcomes

Primary

MeasureTime frame
major adverse cardiac events defined as a composite of all-cause death, MI and TVR by PCI or CABG

Secondary

MeasureTime frame
major bleeding (BARC types 2, 3, or 5 bleeding);ischemia-driven TVR;all-cause death;myocardial infarction;TVR by PCI or CABG;stent thrombosis

Countries

Korea, Republic of

Contacts

Public ContactHyojin Park

Chonnam National University Hospital

h-4427@naver.com+82-62-220-5272

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026